Arthropod-borne Viral Infections Testing Market by Test Type, End-user

Description

List of Tables

[193 Pages Report] The Arthropod-borne Viral Infections Testing Market size was estimated at USD 10.99 billion in 2023 and expected to reach USD 12.18 billion in 2024, at a CAGR 10.88% to reach USD 22.66 billion by 2030.

Global Arthropod-borne Viral Infections Testing Market

KEY MARKET STATISTICS
Base Year [2023]	USD 10.99 billion
Estimated Year [2024]	USD 12.18 billion
Forecast Year [2030]	USD 22.66 billion
CAGR (%)	10.88%

Arthropod-borne Viral Infections Testing Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Arthropod-borne Viral Infections Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Arthropod-borne Viral Infections Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Arthropod-borne Viral Infections Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abnova Corporation, ACROBiosystems, AdvaCare Pharma, ARUP Laboratories, Bio Lab Diagnostics (I) Private Limited, Bio-Rad Laboratories, Inc., Bio-Techne, BIOGENIX INC. PVT. LTD., bioMerieux SA, Chembio Diagnostics, Inc., Clongen Laboratories, LLC, Coppe Laboratories, EIKEN CHEMICAL Co., Ltd., Elabscience Biotechnology Inc., EUROIMMUN AG by PerkinElmer Inc., F. Hoffmann-La Roche Ltd, Hologic, Inc., InBios International, Inc., J Mitra & Co Ltd, Kephera Diagnostics, Merck KGaA, Quest Diagnostics Incorporated, Sonora Quest Laboratories LLC, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Arthropod-borne Viral Infections Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Test Type
- Cultural Tests
- Immunoassays
- Molecular Tests
End-user
- Diagnostic Centers
- Hospitals
- Research Centers
Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Arthropod-borne Viral Infections Testing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Arthropod-borne Viral Infections Testing Market?

3. What are the technology trends and regulatory frameworks in the Arthropod-borne Viral Infections Testing Market?

4. What is the market share of the leading vendors in the Arthropod-borne Viral Infections Testing Market?

5. Which modes and strategic moves are suitable for entering the Arthropod-borne Viral Infections Testing Market?

Product Code: MRR-4103B31E09D4

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Arthropod-borne Viral Infections Testing Market, by Region

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing arthropod-borne viral infections
  - 5.1.1.2. Improvements in arthropod-borne viral diagnostics
  - 5.1.1.3. Government initiatives and awareness campaigns regarding arboviral infections
- 5.1.2. Restraints
  - 5.1.2.1. Product recall incidences of arthropod-borne viral infections diagnostic kits
- 5.1.3. Opportunities
  - 5.1.3.1. Rising acceptance of ELISA-based test diagnostics
  - 5.1.3.2. Technological advancements in testing methods
- 5.1.4. Challenges
  - 5.1.4.1. Difficulties in developing arbovirus animal models for research study and vaccine development
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Arthropod-borne Viral Infections Testing Market, by Test Type

6.1. Introduction
6.2. Cultural Tests
6.3. Immunoassays
6.4. Molecular Tests

7. Arthropod-borne Viral Infections Testing Market, by End-user

7.1. Introduction
7.2. Diagnostic Centers
7.3. Hospitals
7.4. Research Centers

8. Americas Arthropod-borne Viral Infections Testing Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Arthropod-borne Viral Infections Testing Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Arthropod-borne Viral Infections Testing Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape

11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

12.1. Key Company Profiles
- 12.1.1. Abbott Laboratories
- 12.1.2. Abnova Corporation
- 12.1.3. ACROBiosystems
- 12.1.4. AdvaCare Pharma
- 12.1.5. ARUP Laboratories
- 12.1.6. Bio Lab Diagnostics (I) Private Limited
- 12.1.7. Bio-Rad Laboratories, Inc.
- 12.1.8. Bio-Techne
- 12.1.9. BIOGENIX INC. PVT. LTD.
- 12.1.10. bioMerieux SA
- 12.1.11. Chembio Diagnostics, Inc.
- 12.1.12. Clongen Laboratories, LLC
- 12.1.13. Coppe Laboratories
- 12.1.14. EIKEN CHEMICAL Co., Ltd.
- 12.1.15. Elabscience Biotechnology Inc.
- 12.1.16. EUROIMMUN AG by PerkinElmer Inc.
- 12.1.17. F. Hoffmann-La Roche Ltd
- 12.1.18. Hologic, Inc.
- 12.1.19. InBios International, Inc.
- 12.1.20. J Mitra & Co Ltd
- 12.1.21. Kephera Diagnostics
- 12.1.22. Merck KGaA
- 12.1.23. Quest Diagnostics Incorporated
- 12.1.24. Sonora Quest Laboratories LLC
- 12.1.25. Thermo Fisher Scientific Inc.
12.2. Key Product Portfolio

13. Appendix

13.1. Discussion Guide
13.2. License & Pricing